Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Hidden cardiac lesions and psychotropic drugs as a possible cause of sudden death in psychiatric patients: a report of 14 cases and review of the literature.

Frassati D, Tabib A, Lachaux B, Giloux N, Daléry J, Vittori F, Charvet D, Barel C, Bui-Xuan B, Mégard R, Jenoudet LP, Descotes J, Vial T, Timour Q.

Can J Psychiatry. 2004 Feb;49(2):100-5. Review.

PMID:
15065743
2.

Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management.

Fanoe S, Kristensen D, Fink-Jensen A, Jensen HK, Toft E, Nielsen J, Videbech P, Pehrson S, Bundgaard H.

Eur Heart J. 2014 May 21;35(20):1306-15. doi: 10.1093/eurheartj/ehu100. Epub 2014 Mar 18. Review.

PMID:
24644307
3.

Psychiatric medications and sudden cardiac death: putting the risk in perspective.

Howland RH.

J Psychosoc Nurs Ment Health Serv. 2015 Feb;53(2):23-5. doi: 10.3928/02793695-20150122-01. Review.

PMID:
25654571
4.

Psychotropic drugs, cardiac arrhythmia, and sudden death.

Witchel HJ, Hancox JC, Nutt DJ.

J Clin Psychopharmacol. 2003 Feb;23(1):58-77. Review.

PMID:
12544377
5.

[Psychotropic drugs and sudden death].

Carreiro SV, Martins RR, De Carvalho A.

Acta Med Port. 2006 Mar-Apr;19(2):151-64. Epub 2006 Aug 18. Review. Portuguese.

6.

Cardiovascular causes of sudden death in young individuals including athletes.

Basso C, Corrado D, Thiene G.

Cardiol Rev. 1999 May-Jun;7(3):127-35. Review.

PMID:
10423663
7.

Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.

Haddad PM, Anderson IM.

Drugs. 2002;62(11):1649-71. Review.

PMID:
12109926
8.

[Psychopharmaceuticals and arrhythmias].

Binggeli C, Candinas R, Brunckhorst C.

Ther Umsch. 2004 Apr;61(4):279-83. Review. German.

PMID:
15137522
9.

[QTc-prolonging drugs and the risk of sudden death].

Reingardiene D, Vilcinskaite J.

Medicina (Kaunas). 2007;43(4):347-53. Review. Lithuanian.

10.

Clinical management of cardiovascular risks during treatment with psychotropic drugs.

Glassman AH.

J Clin Psychiatry. 2002;63 Suppl 9:12-7. Review.

11.

[Cardiac effects of antipsychotics: mechanism of arrhythmias and sudden cardiac death].

Kecskeméti V.

Neuropsychopharmacol Hung. 2004 Mar;6(1):5-12. Review. Hungarian.

PMID:
15125308
12.

[Relationships between mental and cardiac diseases].

Birkhofer A, Schmidt G, Förstl H.

MMW Fortschr Med. 2005 Oct 20;147(42):38, 40-3. Review. German.

PMID:
16281782
13.
14.

Are psychotropic drugs at therapeutic levels a concern for cardiologists?

Burggraf GW.

Can J Cardiol. 1997 Jan;13(1):75-80. Review.

PMID:
9039069
15.

Sudden cardiac death secondary to antidepressant and antipsychotic drugs.

Sicouri S, Antzelevitch C.

Expert Opin Drug Saf. 2008 Mar;7(2):181-94. doi: 10.1517/14740338.7.2.181 . Review.

16.

Cardiac side effects of psychiatric drugs.

Mackin P.

Hum Psychopharmacol. 2008 Jan;23 Suppl 1:3-14. Review.

PMID:
18098218
17.

Cardiac effects of psychotropic drugs.

Chong SA, Mythily, Mahendran R.

Ann Acad Med Singapore. 2001 Nov;30(6):625-31. Review.

PMID:
11817292
18.

Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.

Vieweg WV, Wood MA, Fernandez A, Beatty-Brooks M, Hasnain M, Pandurangi AK.

Drugs Aging. 2009;26(12):997-1012. doi: 10.2165/11318880-000000000-00000. Review.

PMID:
19929028
19.

[Proarrhythmic (torsadogenic) effects of QT-prolonging non-antiarrhythmic drugs].

Fazekas T, Liszkai G.

Orv Hetil. 2005 Mar 6;146(10):451-60. Review. Hungarian.

PMID:
15835343
20.

Antipsychotic drugs and QT interval prolongation.

Zareba W, Lin DA.

Psychiatr Q. 2003 Fall;74(3):291-306. Review.

PMID:
12918603

Supplemental Content

Support Center